#$%^&*AU2018214135A120180830.pdf#####ABSTRACT OF THE DISCLOSURE The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof. 10505953 1 (GHMatters) P108631.AU.1